Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Leading Life Sciences Manufacturers Renew Verticalnet Subscriptions; Two FORTUNE 500 Pharmaceutical/Medical Device Manufacturers Re-up for Verticalnet On-Demand Solutions
- MALVERN, Pa. -- Verticalnet, Inc. (Nasdaq: VERT), a leading provider of supply management solutions, today announced that two FORTUNE 500TM Life Sciences manufacturers have renewed their subscriptions to Verticalnet's on-demand e-Sourcing solutions.
- Research articles 2005-05-11
- The Life Sciences Industry: Surviving the Toughest of Times Through Venture Funding and Strategic Alliances
- The object of this article is to address not so much the technology or management on which life sciences companies depend, but rather the capital that and, in particular, from what sources this capital is available and on what terms and conditions it can be secured. To accomplish this objective,...
- White papers 2003-09-19
- Effective Manufacturing Planning for Life Sciences Companies
- Life sciences companies are well positioned to make enormous gains in productivity. They possess a unique excellence in data management and ? from drug discovery to consumer products testing to financial decisions ? they are accustomed to bringing an exacting rigor to their activities. Now they have the opportunity to...
- White papers 2003-02-24
- Health Information Technology Value Chain: A Life Sciences Perspective
- This Deloitte report discusses health information revolution. This point of view addresses the major challenges that life sciences companies are facing such as falling research and development productivity, lengthy clinical trials, growing regulatory scrutiny in new medicines and the lack of deep insights into the needs for pharmacogenics products. It...
- White papers 2008-05-19
- Opportunities For Life Sciences Companies In A Consumer-Driven Market
- As consumers assume more personal responsibility for covering their health care costs, and gain increased awareness of treatment options, provider quality levels and price differences, they will want to take even greater control of their medical care decisions. Life sciences companies that recognize that consumerism is here to stay, and...
- White papers 2008-08-29
- Fraud Risk Management In Life Sciences Companies
- Although many life sciences companies are beginning to put controls in place, many have yet to bring together all the necessary ingredients for identifying and preventing fraud. Among other challenges, it is imperative that legal, accounting, marketing, and contracts professionals within an organization collaborate on all fronts to document, monitor,...
- White papers 2007-08-22
- Customer And Reimbursement Support For The Life Sciences Industry: The Need For An evolved Approach
- Customer and Reimbursement Support are among the only forms of direct contact that life sciences companies have with their patients. Developing and strengthening these relationships are increasingly important in nowadays' consumerdriven health system. Particularly in therapeutic areas involving chronic diseases, such relationships can improve the lifetime value of end customers...
- White papers 2008-11-06
Additional Resources
- Swiss life sciences company Novartis has decided not to proceed with an offer for Berna Biotech
- Swiss life sciences company Novartis Basel has decided not to proceed with an offer for Berna Biotech (Bern, Switzerland). Novartis had announced that it was considering the acquisition in November following an offer to Berna from Dutch biotechnology company Crucell Leiden. Crucell is now offering $450m (372m [euro]) for Berna,...
- Research articles 2006-01-23
- EHOB Named Health and Life Sciences Company of the Year
- INDIANAPOLIS -- EHOB, Inc., a leading provider of affordable products effective in the prevention and treatment of pressure ulcers, is announcing today...
- Research articles 2009-05-19
- Diagnosis still positive for MDS: MDS is a quality Canadian health and life sciences company suited for long-term investors
- MDS Inc. (TSE: MHG.B; Recent price: $28; www.mdsintl.com) is an international health and life sciences company. It has four key divisions: The Drug Discovery and Development division provides analytical instrumentation and contract research; The Isotope division provides radio-isotope-based products and technologies; the Diagnostic division provides diagnostic information to healthcare practitioners;...
- Research articles 1999-10-01
- Intel to aggressively pursue life sciences market here, BUSINESS TIMES
- Business Times Malaysia 05-26-2003 INTEL Corp's foray into life sciences will see the world's biggest chipmaker power the operations of an information technology IT firm which is set to ink a deal with a Malaysian life sciences company next Business...
- Research articles 2003-05-26
- IFRS In The Life Sciences
- Analyze the companies that are moving assertively toward International Financial Reporting Standards IFRS, and you'll note several predominant characteristics. Most have global operations, complex organizational structures, and aggressive competition. They are often publicly held. And they frequently are known for innovation and leadership. In other words, they sound a lot...
- White papers 2008-09-12
- Cambrex continues metamorphosis into pure life sciences firm. (Pharmaceuticals).
- THOUGH IT has taken its share of lumps in this year, Cambrex Corp. is chugging along toward its goal of becoming a pure play life sciences company. As part of its transformation, the company is looking to broaden its reach to offer services further ...
- Research articles 2003-06-23
- Hoechst Shareholders Approve Aventis Move Despite Late Filibuster.(merger with Rhone-Poulenc to create life sciences firm)(Brief Article)
- AN OVERWHELMING majority of Hoechst shareholders has voted to approve the company's merger with Rhone-Poulenc to form the life sciences company Aventis. The vote came at a shareholders' meeting in Frankfurt, Germany, late last Friday despite AN...
- Research articles 1999-07-19
- Invitrogen launches i-Path and Boston Life Sciences CEO to present at BIO Annual Convention.
- M2 PRESSWIRE-21 June 2005-US Financial Network: Invitrogen launches i-Path and Boston Life Sciences CEO to present at BIO Annual ConventionC1994-2005 M2 COMMUNICATIONS LTD RDATE:21062005 City of Industry, CA - Biotechnology industry news provide by Financial News USA (OTC: FNWU). Invitrogen Corporation...
- Research articles 2005-06-21
- Luminex Is Highest Ranking Life Sciences Firm on Deloitte & Touche Technology Fast 500; Ranked Number 24, Luminex Grew 21,051 Percent in Five Years
- Business Editors & Health/Medical Writers SAN JOSE, Calif.--BUSINESS WIRE--Oct. 16, 2002 Luminex Corp. (Nasdaq:LMNX), a biotechnology company with headquarters in Austin, Texas, was the highest ranking life sciences company on the 2002 Deloitte & Touche Technology Fast 500, a ranking of the fastest growing technology companies in North...
- Research articles 2002-10-16
- Research and Markets: Gain Insight into Performance and Finance at IBM Life Sciences
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49918) has announced the addition of IBM Life Sciences - Company Profile to their offering.
- Research articles 2007-02-08
- Syneron Named Fastest Growing Life Sciences Company in Deloitte Fast 500 EMEA
- Syneron Medical Ltd. (NASDAQ: ELOS) today announced that it won first place in the Deloitte Technology Fast 500 EMEA for the Life Sciences/Biotech sector and seventh place in the total Fast 500 EMEA program. The Deloitte Technology Fast 500 EMEA program recognizes technology companies that have achieved the fastest rates...
- Research articles 2006-11-28
- Japan's Ito Life Sciences, the parent company of American Peptide Company and Ito Life Sciences Shanghai, based in Ibaraki, is being acquired by Otsuka Chemical Company, of Osaka, Japan, from Itoham Foods
- Japan's Ito Life Sciences, the parent company of American Peptide Company and Ito Life Sciences Shanghai, based in Ibaraki, is being acquired by Otsuka Chemical Company, of Osaka, Japan, from Itoham Foods. No financial details were disclosed.
- Research articles 2008-08-25
- Honeywell sets ambitious targets for new Life Sciences division.(Brief)(Brief Article)
- HONEYWELL HAS realigned its specialty chemicals business to better address the needs of the life sciences market. With the formal launch of Honeywell Life Science this year, the company has established a solid platform for its ambitious growth targ HONEYWELL HAS realigned its specialty...
- Research articles 2002-11-11
- << Previous
- page 1 of 1
- Next >>
Presented by American Express